ATE265526T1 - Genetisch veränderte fibroblasten und ihre verwendung - Google Patents

Genetisch veränderte fibroblasten und ihre verwendung

Info

Publication number
ATE265526T1
ATE265526T1 AT99923531T AT99923531T ATE265526T1 AT E265526 T1 ATE265526 T1 AT E265526T1 AT 99923531 T AT99923531 T AT 99923531T AT 99923531 T AT99923531 T AT 99923531T AT E265526 T1 ATE265526 T1 AT E265526T1
Authority
AT
Austria
Prior art keywords
genetically modified
modified fibroblasts
fibroblasts
genetically
expression
Prior art date
Application number
AT99923531T
Other languages
English (en)
Inventor
Fulvio Mavilio
Original Assignee
Molecular Medicine S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Medicine S P A filed Critical Molecular Medicine S P A
Application granted granted Critical
Publication of ATE265526T1 publication Critical patent/ATE265526T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99923531T 1998-05-08 1999-05-05 Genetisch veränderte fibroblasten und ihre verwendung ATE265526T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI001004A IT1299201B1 (it) 1998-05-08 1998-05-08 Fibroblasti modificati geneticamente e loro uso
PCT/EP1999/003075 WO1999058646A1 (en) 1998-05-08 1999-05-05 Genetically-modified fibroblasts and the use thereof

Publications (1)

Publication Number Publication Date
ATE265526T1 true ATE265526T1 (de) 2004-05-15

Family

ID=11379982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99923531T ATE265526T1 (de) 1998-05-08 1999-05-05 Genetisch veränderte fibroblasten und ihre verwendung

Country Status (8)

Country Link
EP (1) EP1084232B1 (de)
JP (1) JP2002514409A (de)
AT (1) ATE265526T1 (de)
AU (1) AU4037299A (de)
CA (1) CA2331826A1 (de)
DE (1) DE69916829D1 (de)
IT (1) IT1299201B1 (de)
WO (1) WO1999058646A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
WO2003104467A1 (en) 2002-04-25 2003-12-18 Crucell Holland B.V. Means and methods for the production of adenovirus vectors
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
EP1157999A1 (de) * 2000-05-24 2001-11-28 Introgene B.V. Verfahren und Mitteln zur Verbesserung der Haut-Transplantation mittels Genabgabe-Vehikel mit Tropismus für primären Fibroblasten, sowie andere Verwendungsmöglichkeiten für diesen
DE60138403D1 (de) 2000-09-26 2009-05-28 Crucell Holland Bv Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten
JP2010148440A (ja) * 2008-12-25 2010-07-08 Japan Health Science Foundation 組換えアデノウイルス迅速構築システム
US20200338134A1 (en) * 2019-04-26 2020-10-29 Cleveland State University Muscle treatment method using myod mutant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
WO1995012979A1 (en) * 1993-11-08 1995-05-18 The University Of Southern California Compositions and methods for transduction of cells
GB9419048D0 (en) * 1994-09-20 1994-11-09 Watt Diana J Treatment of muscular disorders
CA2269096C (en) * 1996-10-18 2009-12-15 Universite Laval Method for in vitro preconditioning of myoblasts before transplantation

Also Published As

Publication number Publication date
AU4037299A (en) 1999-11-29
EP1084232B1 (de) 2004-04-28
CA2331826A1 (en) 1999-11-18
IT1299201B1 (it) 2000-02-29
JP2002514409A (ja) 2002-05-21
WO1999058646A1 (en) 1999-11-18
ITMI981004A1 (it) 1999-11-08
DE69916829D1 (de) 2004-06-03
EP1084232A1 (de) 2001-03-21

Similar Documents

Publication Publication Date Title
DE58906718D1 (de) Kunststeine, verfahren zur herstellung und verwendung derselben.
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
DE69839815D1 (de) Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
ATE313634T1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
MXPA04004714A (es) Derivados de aril 1,4-pirazina sustituidos.
MY130489A (en) Substituted aryl 1, 4-pyrazine derivatives
DE69917716D1 (de) Protein-deamiderendes Enzym, dafür kodierendes Gen, Verfahren zur Herstellung und Verwendung davon
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
ATE299529T1 (de) Ptc gene und ihre verwendung
WO2003018752A3 (en) An organotypic intestinal culture and methods of use thereof
ATE275417T1 (de) Verwendung von vegf-c und vegf-d genen oder proteinen zur vorbeugung der restenose
DE69113386D1 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
ATE527378T1 (de) Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression
DE69812365D1 (de) Enthaarungsmitteln, verfahren zur herstellung sowie ihre verwendung
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
EP1023005A4 (de) Verfahren zum beschichten von stents mit dna sowie zur in vivo expression von rekombinanten genen von mit dna beschichteten
DE59101580D1 (de) Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.
ATE265526T1 (de) Genetisch veränderte fibroblasten und ihre verwendung
EP0585464A4 (de) Stark wasserabdorbierender reis, verfahren zur dessen herstellung und verwendung.
ATE174629T1 (de) Herstellung von proteinen mittels protein 7b2
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
TR200200278T2 (tr) Kalsilitik bileşimler
TW200503717A (en) Substituted 1,4-pyrazine derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties